@article {3590, title = {Breastfeeding and migraine drugs.}, journal = {Eur J Clin Pharmacol}, volume = {70}, year = {2014}, month = {2014 Nov}, pages = {1313-24}, abstract = {

PURPOSE: Breastfeeding women may suffer from migraine. While we have many drugs for its treatment and prophylaxis, the majority are poorly studied in breastfeeding women. We conducted a review of the most common anti-migraine drugs (AMDs) and we determined their lactation risk.

METHODS: For each AMD, we collected all retrievable data from Hale{\textquoteright}s Medications and Mother Milk (2012), from the LactMed database (2014) of the National Library of Medicine, and from a MedLine Search of relevant studies published in the last 10 years.

RESULTS: According to our review, AMDs safe during breastfeeding are as follows: low-dose acetylsalicylic acid (ASA), ibuprofen, sumatriptan, metoprolol, propranolol, verapamil, amitriptyline, escitalopram, paroxetine, sertraline, acetaminophen, caffeine, and metoclopramide. AMDs compatible with breastfeeding but warranting caution are as follows: diclofenac, ketoprofen, naproxen, most new triptans, topiramate, valproate, venlafaxine, and cyproheptadine. Finally, high-dose ASA, atenolol, nadolol, cinnarizine, flunarizine, ergotamine, methysergide, and pizotifen are contraindicated.

CONCLUSIONS: According to our review, the majority of the revised AMDs were assessed to be compatible with breastfeeding.

}, keywords = {Adrenergic beta-Antagonists, Analgesics, Non-Narcotic, Animals, Anti-Inflammatory Agents, Non-Steroidal, Anticonvulsants, Antidepressive Agents, Breast Feeding, Calcium Channel Blockers, Female, Humans, Migraine Disorders, Tryptamines}, issn = {1432-1041}, doi = {10.1007/s00228-014-1748-0}, author = {Davanzo, Riccardo and Bua, Jenny and Paloni, Giulia and Facchina, Giulia} }